<?xml version="1.0"?>
<rdf:RDF xmlns="http://purl.obolibrary.org/obo/ero/dev/ocre-imports.owl#"
     xml:base="http://purl.obolibrary.org/obo/ero/dev/ocre-imports.owl"
     xmlns:study_design="http://purl.org/net/OCRe/study_design.owl#"
     xmlns:obo="http://purl.obolibrary.org/obo/"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:study_protocol="http://purl.org/net/OCRe/study_protocol.owl#"
     xmlns:snap="http://www.ifomis.org/bfo/1.1/snap#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:research="http://purl.org/net/OCRe/research.owl#"
     xmlns:statistics="http://purl.org/net/OCRe/statistics.owl#">
    <owl:Ontology rdf:about="http://purl.obolibrary.org/obo/ero/dev/ocre-imports.owl">
        <owl:versionInfo rdf:datatype="http://www.w3.org/2001/XMLSchema#string">${ero.ontology.version}</owl:versionInfo>
    </owl:Ontology>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115">
        <rdfs:label xml:lang="en">definition</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000117">
        <rdfs:label xml:lang="en">definition editor</rdfs:label>
        <rdfs:label xml:lang="en">term editor</rdfs:label>
    </owl:AnnotationProperty>
    <owl:AnnotationProperty rdf:about="http://www.w3.org/2000/01/rdf-schema#label"/>
    <owl:AnnotationProperty rdf:about="http://purl.org/net/OCRe/statistics.owl#curator"/>
    <owl:AnnotationProperty rdf:about="http://purl.org/net/OCRe/study_protocol.owl#develop_comment"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Datatypes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.org/net/OCRe/study_design.owl#OCRE100038 -->

    <owl:Class rdf:about="http://purl.org/net/OCRe/study_design.owl#OCRE100038">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://www.ifomis.org/bfo/1.1/span#ProcessualEntity"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase describes the level of a trial required of drugs before (and after) they are routinely used in clinical practice: 
- Phase I trials assess toxic effects on humans (not many people participate in them, and usually without controls); 
- Phase ll trials assess therapeutic benefit (usually involving a few hundred people, usually with controls, but not always); 
- Phase III trials compare the new treatment against standard (or placebo) treatment (usually a full randomised controlled trial). At this point, a drug can be approved for community use. 
- Phase IV monitors a new treatment in the community, often to evaluate longterm safety and effectiveness. [Glossary of Terms in The Cochrane Collaboration]

A trial can be of a combination phase (e.g., I/II).
The concept of phase is not applicable to trials studying certain interventions (e.g., device, procedure, behavioral)</obo:IAO_0000115>
        <obo:IAO_0000117 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</obo:IAO_0000117>
    </owl:Class>
    


    <!-- http://purl.org/net/OCRe/study_design.owl#Phase_0 -->

    <owl:Class rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_0">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 0</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase 0 trial is an exploratory trial involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening study, microdose study). [http://prsinfo.clinicaltrials.gov/definitions.html]</obo:IAO_0000115>
        <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    </owl:Class>
    


    <!-- http://purl.org/net/OCRe/study_design.owl#Phase_1 -->

    <owl:Class rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_1">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 1</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase I trial assesses toxic effects on humans (not many people participate, and usually without controls) [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
        <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    </owl:Class>
    


    <!-- http://purl.org/net/OCRe/study_design.owl#Phase_2 -->

    <owl:Class rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_2">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 2</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase ll trial assesses therapeutic benefit (usually involving a few hundred people, usually with controls, but not always) [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
        <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    </owl:Class>
    


    <!-- http://purl.org/net/OCRe/study_design.owl#Phase_3 -->

    <owl:Class rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_3">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 3</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase III trial compares the new treatment against standard (or placebo) treatment (usually a full
randomised controlled trial). At this point, a drug can be approved for community use. [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
        <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    </owl:Class>
    


    <!-- http://purl.org/net/OCRe/study_design.owl#Phase_4 -->

    <owl:Class rdf:about="http://purl.org/net/OCRe/study_design.owl#Phase_4">
        <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Phase 4</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.org/net/OCRe/study_design.owl#OCRE100038"/>
        <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A Phase IV study monitors a new treatment in the community, often to evaluate longterm safety and effectiveness. [Glossary of Terms in The Cochrane Collaboration]</obo:IAO_0000115>
        <statistics:curator rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Simona</statistics:curator>
    </owl:Class>
    


    <!-- http://www.ifomis.org/bfo/1.1/snap#SpecificallyDependentContinuant -->

    <owl:Class rdf:about="http://www.ifomis.org/bfo/1.1/snap#SpecificallyDependentContinuant"/>
    


    <!-- http://www.ifomis.org/bfo/1.1/span#ProcessualEntity -->

    <owl:Class rdf:about="http://www.ifomis.org/bfo/1.1/span#ProcessualEntity"/>
</rdf:RDF>



<!-- Generated by the OWL API (version 3.4.2018) http://owlapi.sourceforge.net -->

